Democratising clinical trials research to strengthen primary health care
Butler CC. et al, (2025), The Lancet Global Health, 13, e749 - e758
Patients' acceptance of a penicillin allergy de-labelling programme in primary care.
Santillo M. et al, (2025), BJGP Open
Saline nasal irrigation for acute sinusitis (SNIFS II): a randomised controlled pilot trial with nested process evaluation.
Venekamp RP. et al, (2025), BJGP Open
De-labelling erroneous penicillin allergy records in general practice: healthcare professionals' experiences.
Roleston C. et al, (2025), BJGP Open
Democratising the design and delivery of large-scale randomised, controlled clinical trials in primary care: A personal view.
Butler CC., (2024), The European journal of general practice, 30
Cost-effectiveness of C-reactive protein point of care testing for safely reducing antibiotic consumption for acute exacerbations of chronic obstructive pulmonary disease as part of the multicentre, parallel-arm, open, individually randomised, controlled PACE trial.
Sewell B. et al, (2024), BMJ Open, 14
Respiratory Syncytial Virus-related Community Chronic Obstructive Pulmonary Disease Exacerbations and Novel Diagnostics: A Binational Prospective Cohort Study
Wiseman DJ. et al, (2024), American Journal of Respiratory and Critical Care Medicine, 210, 994 - 1001
How, why and when are delayed (back-up) antibiotic prescriptions used in primary care? A realist review integrating concepts of uncertainty in healthcare
Mcleod M. et al, (2024), BMC Public Health, 24
Stigma relating to tuberculosis infection prevention and control implementation in rural health facilities in South Africa — a qualitative study outlining opportunities for mitigation
van der Westhuizen H-M. et al, (2024), BMC Global and Public Health, 2
Favipiravir for COVID-19 in adults in the community in PRINCIPLE, an open-label, randomised, controlled, adaptive platform trial of short- and longer-term outcomes
Hobbs FR. et al, (2024), Journal of Infection, 89
Stop antibiotics when you feel better? Opportunities, challenges and research directions
Borek AJ. et al, (2024), JAC-Antimicrobial Resistance, 6